CNB Financial Corporation logo CCNE - CNB Financial Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 2
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $34.50 DETAILS
HIGH: $35.00
LOW: $34.00
MEDIAN: $34.50
CONSENSUS: $34.50
UPSIDE: 12.56%

Stock News

Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified Solid Tumors

Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified Solid Tumors

CCNE1-directed molecular glue degrader (MGD) induced deep tumor regressions in CCNE1-amplified in vivo models of ovarian, breast, and gastric cancers  CCNE1-directed MGD demonstrated superior selectivity and reduced off-target activity compared to CDK2 inhibitors Oral presentation on April 21, 2026, at 2:30 p.m. PT BOSTON, April 20, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the company will present preclinical data highlighting the potential of its highly selective, first-in-class cyclin E1 (CCNE1)-directed MGD, MRT-55811, to treat CCNE1-amplified solid tumors at the American Association for Cancer Research (AACR) Annual Meeting 2026, being held April 17-22 in San Diego, CA.

Apr 20, 2026 03:00 AM globenewswire.com
Reviewing CNB Financial (NASDAQ:CCNE) & Patriot National Bancorp (NASDAQ:PNBK)

Reviewing CNB Financial (NASDAQ:CCNE) & Patriot National Bancorp (NASDAQ:PNBK)

Patriot National Bancorp (NASDAQ: PNBK - Get Free Report) and CNB Financial (NASDAQ: CCNE - Get Free Report) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership. Analyst Recommendations This is a summary

Apr 16, 2026 09:28 PM defenseworld.net
CNB Financial Corporation Announces Quarterly Dividend for Series A Preferred Stock and Related Depositary Shares Distribution

CNB Financial Corporation Announces Quarterly Dividend for Series A Preferred Stock and Related Depositary Shares Distribution

CLEARFIELD, Pa., April 14, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) (the "Corporation") has announced the declaration of a quarterly cash dividend of $0.4453125 per depositary share (Nasdaq: CCNEP), resulting from the Corporation's declaration of a quarterly cash dividend of $17.8125 per share on its Series A Preferred Stock. The dividend is payable on June 1, 2026, to holders of record as of May 15, 2026.

Apr 14, 2026 12:05 PM globenewswire.com
CNB Bank Joins the Federal Reserve Bank of Philadelphia as a State Member Bank

CNB Bank Joins the Federal Reserve Bank of Philadelphia as a State Member Bank

CLEARFIELD, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CNB Financial Corporation (“CNB”) (NASDAQ: CCNE) today announced that CNB Bank, its wholly-owned banking subsidiary, became a state member bank regulated by the Board of Governors of the Federal Reserve System through the Federal Reserve Bank of Philadelphia effective February 12, 2026. CNB Bank will also continue to be regulated by the Pennsylvania Department of Banking and Securities.

Feb 18, 2026 11:05 AM globenewswire.com
CNB Financial Corporation Announces Quarterly Dividend for Series A Preferred Stock and Related Depositary Shares Distribution

CNB Financial Corporation Announces Quarterly Dividend for Series A Preferred Stock and Related Depositary Shares Distribution

CLEARFIELD, Pa., Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) (the "Corporation") has announced the declaration of a quarterly cash dividend of $0.4453125 per depositary share (Nasdaq: CCNEP), resulting from the Corporation's declaration of a quarterly cash dividend of $17.8125 per share on its Series A Preferred Stock.

Jan 20, 2026 11:05 AM globenewswire.com

Price Targets